Galapagos NV
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
02 jul 2013 - 07:30
Statutory name
Galapagos NV
Title
Galapagos initiates Phase 1 trial as part of its alliance with Janssen Pharmaceutica NV
Comments
GLPG1205 is a first-in-class molecule to enter the clinic
Candidate drug targets inflammation of the bowel
Galapagos receives €6.6 million milestone payment
Date last update: 10 April 2026